Am J Physiol Cell Physiol AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 297: C548-C555, 2009. First published June 24, 2009; doi:10.1152/ajpcell.00502.2008
0363-6143/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow All Versions of this Article:
297/3/C548    most recent
00502.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by McLoughlin, T. J.
Right arrow Articles by Esser, K. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLoughlin, T. J.
Right arrow Articles by Esser, K. A.

MUSCLE CELL BIOLOGY AND CELL MOTILITY

FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner

Thomas J. McLoughlin,1,2 Sierra M. Smith,1 Alissa D. DeLong,1 Hengbing Wang,2 Terry G. Unterman,2 and Karyn A. Esser2,4

1Department of Kinesiology, University of Toledo, Toledo, Ohio; 2Department of Kinesiology, University of Illinois at Chicago, 3Medical Research Unit, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois; and 4Department of Physiology, University of Kentucky, Lexington, Kentucky

Submitted 29 September 2008 ; accepted in final form 22 June 2009

Recent studies indicate that FoxO transcription factors play an important role in promoting muscle atrophy. To study mechanisms mediating effects of FoxO proteins on muscle wasting, FoxO1-estrogen receptor fusion proteins that are activated by treatment with 4-hydroxytamoxifen (4-OH-T) were stably transfected in C2C12 skeletal myoblasts using the pBABE retroviral system and grown into multinucleated skeletal myotubes. Activation of FoxO1 resulted in significant muscle atrophy, which was accompanied by DNA fragmentation, evidenced by terminal deoxynucleotidyl transferase dUTP-mediated nick end labeling. Cells expressing a DNA-binding-deficient form of FoxO1 also exhibited significant atrophy on FoxO1 activation but no hallmark signs of apoptosis. FoxO1 activation resulted in a significant increase in muscle atrophy F-box (MAFbx)/atrogin-1, muscle-specific RING finger protein 1 (MuRF-1), and Bcl-2-interacting mediator of cell death (Bim) gene expression, with no significant increase in Bcl-2/adenovirus E1B 19-kDa-interacting protein 3 (BNip3) gene expression. Although the ability of FoxO1 to induce MuRF-1 gene expression appeared to be independent of DNA binding, expression of MAFbx/atrogin-1 and Bim was significantly blunted in cells expressing DNA-binding-deficient FoxO1. BNip3 gene expression was significantly elevated in DNA-binding-deficient mutant cells. These findings indicate that FoxO1 promotes skeletal muscle atrophy through induction of proteolytic and apoptotic machinery via DNA-binding-dependent and -independent mechanisms.

atrophy; MAFbx/atrogin-1; Bim; BNip3; terminal deoxynucleotidyl transferase dUTP-mediated nick end labeling



Address for reprint requests and other correspondence: T. J. McLoughlin, Dept. of Kinesiology MS #119, Univ. of Toledo, 2801 W. Bancroft St., Toledo, OH 43606 (e-mail: thomas.mcloughlin{at}utoledo.edu).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.